Lexagene Holdings (Lexagene Holdings) Market Cap : $10.94 Mil (As of May. 19, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Lexagene Holdings Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Lexagene Holdings's share price for the quarter that ended in Nov. 2022 was $0.1661. Lexagene Holdings's Shares Outstanding (EOP) for the quarter that ended in Nov. 2022 was 140.50 Mil. Therefore, Lexagene Holdings's market cap for the quarter that ended in Nov. 2022 was $23.34 Mil.

Lexagene Holdings's quarterly market cap declined from May. 2022 ($21.58 Mil) to Aug. 2022 ($18.73 Mil) but then increased from Aug. 2022 ($18.73 Mil) to Nov. 2022 ($23.34 Mil).

Lexagene Holdings's annual market cap increased from Feb. 2020 ($60.97 Mil) to Feb. 2021 ($103.76 Mil) but then declined from Feb. 2021 ($103.76 Mil) to Feb. 2022 ($32.17 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Lexagene Holdings's Enterprise Value for Today is $0.00 Mil.

Lexagene Holdings Market Cap Historical Data

The historical data trend for Lexagene Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings Market Cap Chart

Lexagene Holdings Annual Data

Trend

Mar13

Mar14

Mar15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Market Cap

Get a 7-Day Free Trial

58.30

33.35

60.97

103.76

32.17

Lexagene Holdings Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
Market Cap	Get a 7-Day Free Trial															43.76	32.17	21.58	18.73	23.34

Competitive Comparison of Lexagene Holdings's Market Cap

For the Medical Devices subindustry, Lexagene Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lexagene Holdings's Market Cap Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's Market Cap falls into.

Lexagene Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Lexagene Holdings's Market Cap for the fiscal year that ended in Feb. 2022 is calculated as

Market Cap (A: Feb. 2022 )	=	Share Price (A: Feb. 2022 )	*	Shares Outstanding (EOP) (A: Feb. 2022 )
	=	$0.23294	*	138.107
	=	$32.17

Lexagene Holdings's Market Cap for the quarter that ended in Nov. 2022 is calculated as

Market Cap (Q: Nov. 2022 )	=	Share Price (Q: Nov. 2022 )	*	Shares Outstanding (EOP) (Q: Nov. 2022 )
	=	$0.1661	*	140.497
	=	$23.34

Lexagene Holdings (OTCPK:LXXGQ) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Lexagene Holdings Market Cap Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Lexagene Holdings (Lexagene Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (OTCPK:LXXGQ) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915

Website

https://www.lexagene.com

Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.